Uli Fehrenbach

Humboldt-Universität zu Berlin

Papers

1

Total Citations

5

H-Index

1

About

Uli Fehrenbach is a leading surgical oncologist whose research focuses on optimizing outcomes in hepatobiliary surgery, particularly for liver malignancies such as cholangiocarcinoma, hepatocellular carcinoma, and colorectal liver metastases. His major contributions center on clarifying the clinical role of lymphadenectomy (LAD) during hepatic resections—a topic of longstanding debate. By analyzing data from the StuDoQ|Liver registry, Fehrenbach has provided critical insights into the short-term postoperative outcomes and use cases of simultaneous LAD, helping to refine surgical decision-making in the modern era of liver surgery. His work, including his highly cited 2024 study, has been instrumental in guiding evidence-based practices for lymph node dissection, directly impacting patient recovery and complication rates. With a growing citation footprint, Fehrenbach’s research is widely recognized for bridging gaps in surgical oncology and advancing the safety and efficacy of complex liver procedures. His findings are essential reading for surgeons and researchers seeking to improve prognostic accuracy and postoperative care in hepatobiliary malignancies.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Short-term postoperative outcomes of lymphadenectomy for cholangiocarcinoma, hepatocellular carcinoma and colorectal liver metastases in the modern era of liver surgery: Insights from the StuDoQ|Liver registry
5 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 22
🏛 Institutions: Humboldt-Universität zu Berlin

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago